Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis - Morishita, Kimberly A.; Moorthy, Lakshmi N.; Lubieniecka, Joanna M.; Twilt, Marinka; Yeung, Rae S. M.; Toth, Mary B.; Shenoi, Susan; Ristic, Goran; Nielsen, Susan M.; Luqmani, Raashid A.; Li, Suzanne C.; Lee, Tzielan; et al. (Arthritis & rheumatology (Hoboken, N.J.), 2017)
Keywords: Adolescent; Adrenal Cortex Hormones - therapeutic use; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy; Antineutrophil cytoplasmic antibodies; Azathioprine - therapeutic use; Child; Children; Churg-Strauss syndrome; Cohort Studies; Corticosteroids; Cyclophosphamide - therapeutic use; Damage; Diagnosis; Dosage; Female; Follow-Up Studies; Glomerulonephritis; Humans; Immunosuppressive Agents - therapeutic use; Kidney Diseases - drug therapy; Kidney Diseases - etiology; Leukocytes (eosinophilic); Lung Diseases - drug therapy; Lung Diseases - etiology; Male; Methotrexate - therapeutic use; Mycophenolic Acid - therapeutic use; Patients; Pediatrics; Prospective Studies; Recurrence; Registries; Remission; Remission Induction; Retrospective Studies; Rituximab - therapeutic use; Vasculitis; Wegener's granulomatosis